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Abstract: The angiosome principle was first described by Jan Taylor in 1987 in the plastic 
reconstructive surgery field, providing useful information on the vascular anatomy of the 
human body. Specifically concerning foot and ankle pathology, it may help the clinician to 
select better vascular access and specific strategies for revascularization. This knowledge 
may be particularly beneficial when treating diabetic neuroischemic foot wounds associated 
with particularly aggressive atherosclerotic disease and a poor collateral circulation. The 
implementation of angiosome-based strategies in diabetic infragenicular vascular reconstruc-
tion may afford encouraging wound healing and limb preservation rates using both bypass 
and endovascular techniques. The minimal invasiveness of these novel strategies enables us 
to perform more specific and more distal tibial and/or foot arterial reconstructions, in one or 
multiple targeted vessels. This paper reviews the available literature on this revascularization 
strategy and focuses on the potential benefit of angiosome-guided primary angioplasty for 
diabetic ischemic foot ulcers.
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Introduction
Although surgical bypass still plays a key role in revascularization of critical limb 
ischemia (CLI),1 increasing clinical experience over the past two decades shows 
encouraging results for primary endovascular strategies, with acceptable feasibility, 
low complication rates,2–4 and limb salvage rates comparable with surgery.2–5 Diabetes 
mellitus is becoming increasingly common in CLI presentations featuring pro-
longed foot inflammation or tissue necrosis. This currently involves frail patients 
at high perioperative risk and affected by numerous vascular comorbidities.1,2 This 
specific patient population, with systemic atherosclerosis, neuroischemic limb ulcers, 
gangrene, and sepsis (the so-called “diabetic foot syndrome”) is prone to a higher 
rate of periprocedural surgical complications.1,2,5 Therefore, endovascular techniques 
may have many applications in this field2 because of their low invasiveness, absence 
of scarring, and lack of need for venous conduits.2,6,7 These strategies seem to have 
the advantages of enabling simultaneous multiple vessel recanalization with high 
reproducibility if necessary,6,7 resulting in shorter hospital stays and health care 
expenditure.1–7Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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Common revascularization issues  
in diabetic patients
The diabetic ischemic foot, because of its multifaceted 
pathology, presents well recognized challenges for the 
vascular interventionist. Chronically and critically oxygen-
deprived tissues in these frail patients often develop ulcers, 
extended sepsis, and limb edema. Heavily calcified and 
occluded calf and foot arteries make all types of vascular 
reconstruction more difficult.1,2,6 Not surprisingly, the main 
infragenicular arterial axis that supplies the distal wound 
territory is frequently affected by severe atherosclerotic 
disease.4,8–10 Current critical limb ischemia data suggest 
that bypass using vein grafts achieves 79%–90% limb sal-
vage rates at 1 year,8 while below-knee angioplasty affords 
technically successful recanalization rates of up to 80%, 
with comparable rates of limb preservation.1,5,8 However, 
these series have a heterogeneous Rutherford grade II–III 
component and class 4–6 presentation.1,8 It is generally 
accepted for distal bypass and endovascular reconstruc-
tions that the outflow vessel based on angiographic details 
modulates the strategy for vascular reconstruction and 
enables technical success and good postoperative patency.1,8 
From this perspective, the aim is to reirrigate the distal 
ischemic wound territory directly, but is often achieved 
indirectly via collaterals surrounding the diseased zone. 
The decision-making process often focuses on the most 
suitable artery to be reopened or a patent distal vessel to 
anchor the bypass.1,2,6–8
In the last two decades, some authors have proposed 
complementary topographic orientations in critical limb 
ischemia revascularization, because the choice of the most 
appropriate target vessel starts from a clinical point of view, 
ie, the wound location.9–11 They have described particular 
tissue sectors of the human body depending on specific arte-
rial and venous irrigation sources, named “angiosomes”.9–14 
The distribution of these angiosomes was eventually 
sought to harmonize already used arterial reconstruction 
techniques.10–12
Angiosomes and limb salvage
Parallel efforts to decrease diabetic limb losses have unfolded 
in the field of plastic reconstructive surgery, by promoting 
the angiosome model of perfusion.9–14 This concept is based 
on the anatomical studies of Taylor et al9,12 and Attinger 
et al,10,11,13,14 who pioneered preferential strategies for surgi-
cal access, tissue reconstruction, and amputation, follow-
ing specific three-dimensional tissue sectors of the body, 
ie, angiosomes in specific arteriovenous bundles.
Practical implementation of the angiosome concept in 
daily limb salvage bypass or transcatheter techniques started 
only a few years ago. Although few results have been pub-
lished as yet, and mainly in the vascular interventional field, 
retrospective studies seem to favor this hypothesis.14–17 In a 
retrospective surgical series of 48 patients, Neville et al15 
found a 91% healing rate with a 9% amputation rate in the 
angiosome-guided group vs a 62% healing rate and 38% 
amputation rate in the nonangiosome-guided group. In 203 
consecutive limbs with critical ischemia and ischemic ulcer-
ations undergoing endovascular reconstruction, Iida et al18 
reported limb preservation in 86% of the angiosome-related 
group compared with 69% in the nonspecific treatment 
group. Consistent with these reports, in a similar series of 
76 ischemic ulcers treated by both bypass and endovascular 
therapies, Varela et al19 noted significant better results for 
wound healing (92% vs 73%) and limb salvage (93% vs 
72%) in the angiosome-guided cohort of patients. We have 
previously published our experience in 98 diabetic patients 
with ischemic foot ulcers treated by angiosome-oriented 
primary angioplasty, with similarly encouraging results 
for limb preservation (91%, 88%, and 84% at 12, 24, and 
36 months, respectively) and wound healing (85%, 81%, and 
73% at the same time intervals).17
In practical terms, the angiosome concept delineates the 
human body into three-dimensional tissue blocks irrigated 
by specific arteriovenous sources.9–12 Adjacent angiosomes 
are interconnected by numerous “choke vessels” that cre-
ate an integrated compensatory system between different 
territories.9–14 Although not part of everyday practice, this 
model already has some contemporary clinical applications, 
including specific myocardial revascularization, selective 
visceral embolization, characteristic types of covering 
flaps,9,12 incisions or amputations10,14 in plastic reconstruc-
tive surgery,9–14 and, more recently, targeted bypass or 
endovascular revascularization for limb salvage in critical 
limb ischemia.11,13–19 In the lower limb, five angiosomes 
were initially described9,12,13 in the foot and lower ankle9–11,13 
emerging from the three main tibial trunks, ie, the anterior 
and posterior tibial arteries joined to the peroneal vessels.
Schema for foot and lower ankle 
angiosomes
Schematically, the distribution of angiosomes12–17 in the 
foot encompasses: the medial calcaneal, medial plantar, and 
lateral plantar artery angiosomes derived from the posterior 
tibial artery supplying the entire plantar heel and the medial 
and lateral plantar surface beyond the toes; the dorsalis pedis Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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angiosome, which extends from the anterior tibial artery, sup-
plying the dorsum of the foot and toes, and also upper anterior 
perimalleolar vascularization; and the lateral calcaneal artery 
angiosome (optionally adding the lateral perimalleolar artery 
angiosome) derived from the peroneal artery, covering the lat-
eral and plantar heel and succeeding the anterior peroneal per-
forating branch, that connects the latter to the anterior tibial 
territory (Figure 1). Going up to the superior ankle and distal 
calf zones, other angiosome territories have been identified, 
including the anterior perforator artery angiosome (from the 
peroneal artery) and the lateral malleolar angiosomes with 
the corresponding medial malleolar angiosomes from the 
anterior-tibial artery.9,11,12 Some of these perimalleolar angio-
somes have been additionally considered by recent reports of 
revascularization procedures.15,16,18 A few examples of current 
angiosome-guided endovascular interventions for diabetic 
neuroischemic foot wounds are shown in Figures 2–9.
The diabetic foot is a preferential application for topo-
graphic revascularization. Availability of the angiosome strat-
egy for infragenicular revascularization seems to   represent 
a particular interest in diabetic patients for several reasons. 
It has been suggested that the neuroischemic diabetic foot 
is associated with more distal and aggressive atherosclerotic 
macroangiopathy, as well as functional microcirculatory 
impairment induced by both neuropathy and local sepsis.20,21 
In this specific context, featuring multiple blockades of 
large and medium-sized foot arteries,20 O’Neal has outlined 
the concept of diabetic end-artery occlusive disease.21 This 
hypothesis considers critical irrigation to the foot, whereby 
medium-sized “patchy atherosclerosis” is associated with 
acute septic thrombosis and loss of small collaterals with 
surrounding inflammation.21 The end-artery occlusive disease 
theory21 probably explains better why irrigation from a few 
millimeters of skin to the entire diabetic foot or leg11,16,17,21 
relies on specific nourishing vessels, although solely hinged 
to one specific dominant angiosome-dependent artery.9–12 
Consequently, it might be emphasized that in these subjects, 
the more distal and specific the revascularization, the higher 
the probability of re-establishing an adequate blood supply 
in a specific amount of threatened tissue.
Figure 1 A simplified illustration of previously suggested angiosomes of the foot and lower ankle.
Abbreviations: DP, dorsalis pedis artery angiosome; LP, lateral plantar artery angiosome; MP, medial plantar artery angiosome; LC, lateral calcaneal artery angiosome;   
MC, medial calcaneal artery angiosome.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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Figure 2 Selective revascularization of the posterior tibial and lateral plantar artery angiosome: (a–f) Staged angioplasties in the posterior tibial artery. (g–i) Selective 
angioplasties in the lateral plantar artery and its appended angiosome.
Figure 3 Clinical correspondence of the angiographic pattern showed in Figure 2. A neuroischemic plantar ulcer in an acute diabetic foot presentation: (a) Initial clinical aspect 
featuring a lateral plantar artery hypoperfusion and sole forefoot abscess. (b) and (c) Abscess drainage and debridement. (d) and (e) Clinical evolution at weeks 3 and 5.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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Figure 4 Selective revascularization of the distal posterior tibial artery and its 
appended medial plantar artery angiosome. (a) and (b) Selective angioplasty in the 
posterior tibial artery, and (c) and (d) specific revascularization of the medial plantar 
artery and its angiosome.
Figure 5 A right hallux neuroischemic sole ulceration matching the angiographic 
features showed in Figure 4. There is medial plantar artery hypoperfusion in an 
end-artery occlusive disease pattern for the first toe. (a) Initial presentation and   
(b) clinical evolution at 1 month after angioplasty. (c) Results 2 months later.
Figure 6 Global medial and lateral plantar artery critical ischemia and acute diabetic foot syndrome matching staged occlusions in the posterior tibial artery (with end-artery 
occlusive disease model to the sole). (a) Prime posterior tibial artery staged subocclusive lesions. (b) and (c) The reestablished flow in the posterior tibial and both right 
plantar arteries. (d) The initial clinical aspect. (e) Subsequent evolution at 3 weeks. (f) Clinical results after 5 months of team surveillance.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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The association between the end-artery occlusive disease 
theory21 and the broader angiosome concept may reveal 
promising results in diabetic wound regeneration,13,15–19,22 
particularly if specific pedal and/or plantar revascular-
izations are added to those of the tibial trunk14,17,18,23 in 
single   interventions. This also underscores the advantage of 
endovascular strategies to allow multiple below-knee and 
below-ankle vessel reconstructions, in addition to surgery. 
On the complex background of a diabetic foot, the angio-
some concept may equally allow vascular interventionists to 
select more specific wound-oriented vascular reconstruction 
with probably a better prognosis in terms of tissue healing, 
as suggested in recent reports by Setacci et al,16 Clemens 
and Attinger,22 and Bazan.24 Beyond the initial clinical ori-
entation (focusing on the specific location of foot ulcers, 
Figures 1–9), other laboratory examinations may help the 
clinician to choose the appropriate angiosome for revascular-
ization, ie, Doppler assessment of the dominant foot arch,11–13 
angiographic computed tomographic or magnetic resonance 
evaluation of homolateral and contralateral limb arterial 
patterns,17 and transcutaneous oxygen pressure monitoring 
stratification in adjacent angiosomes.17
Challenging endovascular 
procedures in diabetic 
infragenicular trunks
Figures 2, 4, 7, and 9 show the main categories of targeted 
angiosome revascularization and indicate the presence of 
specific calcifications in the tibial, dorsal foot, or plantar 
diabetic arteries. These calcific deposits represent one of the 
major technical concerns for the vascular interventionist.2,6,17 
Inasmuch as nondiabetic subjects seem to develop intimal, 
eccentric, and patchy arterial wall calcific deposits (ie, type 
I calcifications),25 diabetic infrapopliteal atherosclerosis 
affects the medial layer, with mostly concentric continu-
ous wall calcifications ( “Mönckeberg sclerosis” or type II 
calcification).25 Although the precise etiology is unknown, 
their severity and spread have been related to the duration 
Figure 7 Selective anterior tibial and related dorsalis pedis artery angiosome: (a–c) Primary staged anterior tibial angioplasty, (d) initial dorsal foot ulceration, (e) clinical 
results at 1 month following (f–h) associated dorsalis pedis selective angioplasty.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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of diabetes, concomitant autonomic neuropathy, and specific 
alterations in the vasa vasorum.10,25 Type II calcifications 
undoubtedly present challenges for revascularization using 
endoluminal or surgical techniques in these rigid conduits with 
a diameter of only 2 or 3 millimeters.3,17,23,26 This observation 
becomes even more manifest when choosing an angiosome 
orientation for tibial revascularization,17,19,26 acknowledging 
that the appropriate angiosome-dependent artery may not nec-
essarily be the simplest vessel to treat.15–17 It has been shown 
that severely ischemic territories with tissue loss more often 
include long segments of chronic and calcific arterial occlu-
sions in the corresponding angiosome-related vessels.16–19
Another challenging factor to be faced by the vascular 
specialist when planning treatment of a diabetic ulcer is the 
control of local neuropathy. Beyond chronic exposure of the 
foot with sensory loss to microtrauma, skin tears, and defor-
mation, neuropathy adds characteristic functional microcircu-
latory impairment16 by autonomic denervation.16,20,21 The latter 
strongly affects residual perfusion of the skin by capillary 
steal, impairing the local healing process16,21 and consequently 
the distal arterial runoff to the foot (an important consideration 
in any vascular reconstruction).16,20 An additional element 
of the diabetic environment is local sepsis. This component 
of the diabetic foot puzzle commonly causes purulent col-
lections, swelling, and adjacent hyperpressure in the form 
of foot compartment syndromes.20,21 A consequent neural 
(peripheral entrapment) and remote arterial collateral deple-
tion has been described.20,21,26 Therefore, the compensatory 
capillary network of angiosomes (ie, “choke” vessels)9–14,16,26 
seems strongly determined by the duration of diabetes and 
Figure 8 Specific posterior tibial and adjacent medial calcaneal artery angiosome 
revascularization in heel related wound. (a) Tight stenosis in the distal posterior 
tibial artery, above emergence of the medial calcaneal branch, (b) Angiographic 
result after selective angioplasty, (c) initial presentation of heel ulcer, and (d) clinical 
results after 5 weeks of team surveillance.
Figure 9 Lateral calcaneal artery and peroneal main flow-related angiosome ulceration. (a, b) Initial pattern of perfusion featuring the peroneal artery as single and severely 
diseased (end-artery occlusive model) calf vessel, (c) re-established flow in the peroneal territory, (d) prime aspect of lateral calcaneal and inframalleolar tissue defect, and 
(e–g) subsequent clinical evolution at weeks 1, 5, and 6.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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chronic inflammation,20,21,26 indicating the need to treat isch-
emic foot areas by more distal and more specific vascular 
reconstructions.15–17 These specific diabetic foot challenges 
seem to increase the postoperative risk in terms of tissue 
recovery6,14,16,17,20,26 which may still jeopardize limb salvage 
after successful revascularization.14,16,21,26 Because the angio-
some strategy seems to be advantageous when performing 
revascularization,14–16,18,24 with particular utility in the diabetic 
foot ischemic model,13,17,22 it seems reasonable to predict an 
increasing role for this concept16,17,19,24 in an era of expanding 
endovascular applications, including the “first approach”26–29 
and hybrid surgical and transcatheter procedures.27,28
Limitations and challenges  
of angiosome-based strategies
Our group has encountered two main challenges while using 
the angiosome strategy for infragenicular angioplasty. First, 
the angiosome concept of revascularization has shifted our 
indications from “which vessel is most suitable for revascu-
larization” to a multidisciplinary clinical consideration of 
“which region of perfusion governed by which artery should 
be treated?” This policy has engaged our vascular group in 
more laborious procedures, acknowledging that the most suit-
able angiosome-dependent artery to treat may not necessarily 
be the simplest vessel to recanalize.15–19 As emphasized earlier, 
extended calcifications in long segment chronic occlusions or 
tight stenoses are commonly encountered during angiosome-
targeted revascularization. Following local learning curves 
and evolving skills, our initially observed global technical 
failure rate of  20%17 seems to match similar critical limb isch-
emia angioplasty feasibility reports, ranging from 69%–85% 
for occlusions and 77%–95% for severe stenoses.3–7,30,31 In 
an attempt to address these technical limitations, we have 
favored antegrade approaches, long (50–70 cm) sheaths 
reinforced by stiff catheters (Lumax/Cook, UK or 5-French 
Pier, Cordis, New York, NY) and a stiff shaft with 0.018 in 
over-a-wire balloons (ReeKross, Clear Stream Technologies 
Ltd, Wexford, Ireland). Occasionally, in heavily calcified ves-
sels, cutting balloons (Boston Inc, Fall River, MA) or blunt 
microdissection devices (Frontrunner, Cordis) have been 
used to improve access (Figures 2 and 3). New endovascular 
techniques (eg, tibial retrograde approaches) or recanalization 
devices based on rotational endarterectomy, excimen laser, 
or ultrasound debulking therapy, have seldom been used by 
our team, but may offer promise for mandatory topographic 
recanalization.23,26,31,33
The second limitation relates to occasional anatomical 
variation of the main angiosome boundaries between patients. 
Although constant in number,10–14 each of the main arterial 
bundles in the ischemic foot and ankle remains strongly 
dependent on the collateral supply.10–13,18,19 The end-artery 
occlusive disease theory21 referred to earlier emphasizes 
the deficiency of medium-sized and small-sized collateral 
networks9,14 in the diabetic foot syndrome, the angiosome 
equivalents of which being the choke vessels. Unlikely 
nondiabetic critical limb ischemia presentations, diabetic 
neuroischemic wound territories show major collateral 
deterioration,20–22,32 with no opportunity for a compensatory 
collateral circulation.21,32 The amount of tissue depending 
on one specific arterial source to be reopened varies from a 
few square millimeters of skin, to the entire foot or leg.21 In 
our experience, in presentations showing complex overlap-
ping wounds with adjacent angiosomes with questionable 
collateral resources, we orient procedures toward tandem or 
multiple angiosome reopening, if technically feasible.
Recent reports of infragenicular-
targeted revascularizations
In a recent review of our group experience based on multidis-
ciplinary follow-up, we compared the efficacy of below-knee 
angioplasty in two consecutive cohorts of diabetic patients 
with and without the angiosome concept.32 Although not 
reaching statistical significance for primary (P = 0.813) and 
secondary patency (P = 0.511), we found a significant differ-
ence in wound healing (hazards ratio [HR] 2.19, P = 0.025) 
and limb preservation (HR: 2.32, P = 0.035) between these 
consecutive groups, with better results for angiosome-guided 
revascularization.32 In the same retrospective analysis,32 
although the number of initial technical failures in the 
angiosome-guided primary angioplasties was marginally 
higher (21% vs 18% for more challenging lesions), we 
observed no significant difference (P , 0.05) in terms of need 
for reintervention or perioperative morbidity and mortality 
between angiosome-oriented vs nonangiosome-oriented 
angioplasties.32 Other published reports have found parallel 
healing/nonhealing and limb salvage rates, ie, 91% vs 62%15 
compared with 85% vs 76% in our group32 and 86% vs 69%,18 
analogous to 90% vs 84% in our registry data.32 In summary, 
there has been equal benefit for both surgery and endovascu-
lar strategies using angiosome-guided approaches.15,19,32
The BASIL (Bypass versus Angioplasty in Severe Ischae-
mia of the Leg) trial5 reports similar early amputation-free 
survival rates for surgery and endovascular techniques in 
nontopographic below-knee revascularizations, although less 
than one third of patients had diabetes. The same prospective 
study did not detect a significant decrease in survival rates for Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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diabetic subjects using both therapeutic options.5,31 A recent 
analysis conducted by O’Brien-Irr et al33 studied the clini-
cal outcome of 106 cases divided in Rutherford category 4 
and 5 chronic limb ischemia presentations and following 
infrainguinal endovascular treatment, comprising 32% and 
58% of diabetic patients, respectively. The authors found that 
for Rutherford category 5 cases, comparable limb salvage 
rates were 82%, with early wound healing occurring in only 
21% of cases without target extremity revascularization. 
They concluded that refining patient selection and clinical 
indications may substantially improve the outcome of percu-
taneous transluminal angioplasty.33 Hoping to provide more 
accurate information upon the tibial runoff and the collateral 
reserve in each critical limb ischemia pattern of presentation, 
Mustapha et al34 recently proposed an original classification 
and interventional protocol for AM-guided below-knee inter-
ventions. They graded from 0–3 different types of ischemic 
crural patterns, adding a three-level collateral scoring system 
that may help the interventionist to better choose the target 
artery and consequent chronic total occlusion (CTO) strategy 
to be deployed.34
Angiosome concept as a 
component of diabetic team work
Contemporary clinical experience suggests that using the afore-
mentioned new technologies and principles of treatment, like 
the angiosome concept, a linear correlation between successful 
revascularization and unreserved tissue healing is difficult to 
ascertain20,26,27 unless appropriate multidisciplinary surveil-
lance is undertaken. This seems particularly true for diabetic 
neuroischemic foot wounds.14,16,17,20,22,26–29 It is also generally 
accepted that people with diabetes should be offered specific 
education about preventive foot care.20,29,35 The effectiveness of 
any educational program is critically linked to the availability of 
complementary clinical services.36 Trying to merge primary (the 
patient) with secondary (the medical team) prevention in the 
diabetic foot group at our institution, we have included patients 
and their general practitioners as members of the team, with 
their active participation in all therapeutic decisions.
Conclusion
Implementation of angiosome-based strategies in infragen-
icular interventions may improve wound healing and limb 
preservation rates using bypass and endovascular techniques. 
It may also offer the opportunity in primary angioplasty to 
orient pedal/plantar revascularizations more specifically and 
more distally. Incorporating the angiosome model in con-
temporary below-knee team strategies for revascularization 
might be useful, although further comparative and prospec-
tive data are needed to evaluate this concept fully.
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